Cart summary

You have no items in your shopping cart.

LDN-214117

SKU: orb1226029

Description

A potent and selective ALK2 inhibitor with a biochemical IC50 of 24 nM, a cell-based IC50 for BMP6 of 100 nM; displays 164-fold selectivity for BMP6 versus TGF-β1; a highly selective probes of BMP-mediated cellular physiology.

Images & Validation

Key Properties

CAS Number1627503-67-6
MW419.5161
Purity>98% (HPLC)
FormulaC25H29N3O3
SMILESCOC1=C(OC)C(OC)=CC(C2=C(C)N=CC(C3=CC=C(N4CCNCC4)C=C3)=C2)=C1
TargetTGFBR
Solubility10 mM in DMSO

Bioactivity

In Vivo
LDN-214117 (p.o. , 25 mg/kg, daily, for 14 days) has well-tolerated in mice. Animal model: NOD. SCID mice. Dosage: 25 mg/kg. Administration: p.o. , daily, for 14 days. Result: Showed good-tolerated in mice.
In Vitro
LDN-214117 has high inhibition and selectivity for ALK2 kinase proteins with an IC50 value of 24 nM. LDN-214117 has kinase activity for ALK1, ALK3 and ALK5 with IC50 values of 27 nM, 1, 171 nM and 3, 000 nM, respectively. LDN-214117 exhibits relatively selective inhibition for BMP6, BMP2 and BMP4 with IC50 values of 100 nM, 1, 022 nM and 960 nM, respectively. LDN-214117 has inhibition of TGF-β1-induced transcriptional activity with an IC50 values of 16, 000 nM. LDN-214117 (5 μM, 30 min, 3 h and 24 h) has time-dependent effect activity on gene regulation level and/ or a BMP signaling pathway other than SMAD-dependent that is responsible for ID1 targeting. LDN-214117 (5 μM, 24-120 h) reduces viability, proliferation and causes apoptosis of lung carcinoma cells LCLC-103H. LDN-214117 (5 μM, 0-48 h) suppresses wound healing and chemotactic potential of LCLC-103H cells. LDN-214117 (5 μM, 48 h) hinders growth of multicellular LCLC-103H spheroids. Cell Viability Assay Cell line: LCLC-103H cells. Concentration: 5 μM. Incubation time: 24 h, 48 h, 72 h and 96 h. Result: Decreased markedly with time, counting approximately 60% of the vehicle control level at the 96-h measurement point. Western blot analysis. Cell line: LCLC-103H cells. Concentration: 5 μM. Incubation time: 30 min, 3 h and 24 h. Result: Diminished the increase of ID1 protein. Apoptosis Analysis Cell line: LCLC-103H cells. Concentration: 5 μM. Incubation time: 24 h, 48 h, 72 h and 96 h. Result: Induced considerable death of LCLC-103H cells. RT-PCR Cell line: LCLC-103H cells. Concentration: 5 μM. Incubation time: 24 h, 48 h and 72 h. Result: Induced distinct gene expression patterns for the two EMTTFs. Cell Migration Assay Cell line: LCLC-103H cells. Concentration: 5 μM. Incubation time: 0 h, 24 h and 48 h. Result: Significantly hindered the migration of LCLC-103H cells into the wound area by Inhibiting of BMP signaling.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

LDN214117

Similar Products

  • LDN-214117 [orb1307025]

    >99.99% (May vary between batches)

    1627503-67-6

    419.52

    C25H29N3O3

    2 mg, 5 mg, 50 mg, 10 mg, 1 ml x 10 mM (in DMSO), 25 mg, 100 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

LDN-214117 (orb1226029)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

200 mg
500 mg
2 mg
$ 80.00
5 mg
$ 100.00
10 mg
$ 150.00
25 mg
$ 270.00
50 mg
$ 430.00
100 mg
$ 650.00